CAR-ENGINEERED PRIMARY NK CELLS SHOW PROMISING EFFECTS AS TARGETED THERAPY AGAINST EGFR-POSITIVE GLIOBLASTOMA

被引：0
|
作者：
Roller, B. [1 ,2 ]
Reindl, L. [2 ,3 ]
Strassheimer, F. [1 ,2 ]
Ziegener, L. [1 ,2 ]
Elleringmann, P. [1 ,2 ]
Kiefer, A. [4 ]
Roeder, J. [2 ,4 ]
Steinbach, J. [1 ,2 ]
Wels, W. [2 ,4 ]
Ullrich, E. [3 ]
Burger, M.
机构：
[1] Dr Senckenberg Inst Neurooncol, Frankfurt, Germany
[2] Goethe Univ Frankfurt, Frankfurt Canc Inst FCI, Frankfurt, Germany
[3] Goethe Univ, Childrens Hosp, Frankfurt, Germany
[4] Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, Frankfurt, Germany
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae144.217
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P12.04.A
引用
收藏
页码：V66 / V66
页数：1
相关论文
共 50 条
  • [31] A novel nanobody as therapeutics target for EGFR-positive colorectal cancer therapy: exploring the effects of the nanobody on SW480 cells using proteomics approach
    Thomanai Lamtha
    Sucheewin Krobthong
    Yodying Yingchutrakul
    Pawitrabhorn Samutrtai
    Christopher Gerner
    Lueacha Tabtimmai
    Kiattawee Choowongkomon
    Proteome Science, 20
  • [32] Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft model
    Tachi, Tetsuro
    Kijima, Noriyuki
    Kuroda, Hideki
    Ikeda, Syunya
    Murakami, Koki
    Nakagawa, Tomoyoshi
    Yaga, Moto
    Nakagawa, Kanji
    Utsugi, Reina
    Hirayama, Ryuichi
    Okita, Yoshiko
    Kagawa, Naoki
    Kishima, Haruhiko
    Imai, Chihaya
    Hosen, Naoki
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (12)
  • [33] Genetically engineered CAR NK cells display selective cytotoxicity against FLT3-positive B-ALL and inhibit in vivo leukemia growth
    Oelsner, Sarah
    Waldmann, Anja
    Billmeier, Arne
    Roeder, Jasmin
    Lindner, Aline
    Ullrich, Evelyn
    Marschalek, Rolf
    Dotti, Gianpietro
    Jung, Gundram
    Grosse-Hovest, Ludger
    Oberoi, Pranav
    Bader, Peter
    Wels, Winfried S.
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (07) : 1935 - 1945
  • [34] CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC)
    Nowak, Juliette
    Bentele, Marco
    Kutle, Ivana
    Zimmermann, Katharina
    Luehmann, Jonathan Lukas
    Steinemann, Doris
    Kloess, Stephan
    Koehl, Ulrike
    Rossberg, Willi
    Ahmed, Amed
    Schaudien, Dirk
    Neubert, Lavinia
    Kamp, Jan-Christopher
    Kuehnel, Mark P.
    Warnecke, Athanasia
    Schambach, Axel
    Morgan, Michael
    CANCERS, 2023, 15 (12)
  • [35] Efficacy of the induced pluripotent stem cell derived and engineered CD276-targeted CAR-NK cells against human esophageal squamous cell carcinoma
    Lin, Xiaolan
    Guan, Tian
    Xu, Yien
    Li, Yun
    Lin, Yanchun
    Chen, Shaobin
    Chen, Yuping
    Wei, Xiaolong
    Li, Dongsheng
    Cui, Yukun
    Lin, Yan
    Sun, Pingnan
    Guo, Jianmin
    Li, Congzhu
    Gu, Jiang
    Yang, Wei
    Zeng, Haoyu
    Ma, Changchun
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [36] Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells
    L. Herrera
    S. Santos
    M. A. Vesga
    J. Anguita
    I. Martin-Ruiz
    T. Carrascosa
    M. Juan
    C. Eguizabal
    Scientific Reports, 9
  • [37] Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against cd19 positive leukemic cells
    Herrera, L.
    Santos, S.
    Vesga, M. A.
    Anguita, J.
    Martin-Ruiz, I.
    Carrascosa, T.
    Juan, M.
    Eguizabal, C.
    HUMAN GENE THERAPY, 2019, 30 (11) : A59 - A59
  • [38] Adult Peripheral Blood and Umbilical Cord Blood NK Cells Are Good Sources for Effective Car Therapy Against CD19 Positive Leukemic Cells
    Herrera, Lara
    Santos, Silvia
    Angel Vesga, Miguel
    Anguita, Juan
    Martin-Ruiz, Itziar
    Carrascosa, Tomas
    Juan, Manel
    Eguizabal, Cristina
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 263 - 264
  • [39] Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells
    Herrera, L.
    Santos, S.
    Vesga, M. A.
    Anguita, J.
    Martin-Ruiz, I.
    Carrascosa, T.
    Juan, M.
    Eguizabal, C.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [40] ADULT PERIPHERAL BLOOD AND UMBILICAL CORD BLOOD NK CELLS ARE GOOD SOURCES FOR EFFECTIVE CAR THERAPY AGAINST CD19 POSITIVE LEUKEMIC CELLS
    Herrera, L.
    Santos, S.
    Vesga, M. A.
    Anguita, J.
    Martin-Ruiz, I.
    Carrascosa, T.
    Juan, M.
    Eguizabal, C.
    HUMAN GENE THERAPY, 2019, 30 (12) : A18 - A18
12345